Pioneering a New Way for Women to Treat Vaginosis with Microbicidal Light
Cern Device
Cern Corporation, The Cern Device...Microbicidal light treatment for both yeast & bacterial vaginosis. Without Drugs!
In a recent Providence Healthcare article, Dr. Melanie Santos, MD , Cern's Chief Medical Office and Medical Director of Pelvic Health for St. Jude Medical Center in Fullerton, California, explains the different types of vaginal infections women face and offers tips to help women recognize and treat this common condition.
Here's what vaginitis is and how Cern is pioneering a new way to solve for the problem.
What is Vaginitis?
“Vaginitis refers to infection or inflammation of the vagina. It occurs when the natural balance between yeast and bacteria becomes unbalanced. This can lead to inflammation, swelling and infection of the vagina,” Says Dr. Santos.
Vaginitis does not always produce any noticeable symptoms, according to Dr. Santos. If recognizable symptoms do develop, they often include:
“Vaginal infections can occur at any age, but they are most common from late teens through early forties and can also increase after menopause. They are different than a sexually transmitted infection (STI). You can develop a vaginal infection without being active with sexual partners. However, some forms of sexual activity may trigger or worsen the condition,” she adds.?
How does Cern's Device Solve Vaginitis in a New Way?
The Cern Device? is designed to serve as an insertable vaginal device, enabling at-home treatment of fungal and bacterial vaginosis, without the need for oral or topical medications.?With that, we believe the Cern Device? is the only patented Microbicidal Light device for these treatments, offering women a safe, convenient alternative for use at home when needed, as needed based on familiar symptoms.
领英推荐
Shaped and sized similar to a tampon, the Cern Device? can be inserted for 20-40 minutes - aiming to effectively control both bacterial and or fungal infection based on dosage. In a healthy microbiome, naturally occurring yeast and bacteria reside together in a symbiotic relationship. Infections tend to occur when an imbalance or dysbiosis occurs.?
The?Cern Device??will utilize specific wavelengths of light to disrupt the pathogen’s DNA - inhibiting the cell's ability to reproduce - and thus, will be able to restore the microbiome to a state of symbiosis.
The FDA is familiar with low-level microbicidal light and its mechanism of action, yet surprisingly, we don’t think they’ve seen products on the market today for this application. Cern believes this creates what many view as a new white space opportunity, which Cern has identified, received patents for, and is addressing.
Managing Director/Tytran Ventures, LLC
1 年Great piece; very innovative concept with tremendous market application in unmet need. To more and better!
Amplifying Health Equity with Data and AI
2 年Cern Corporation, Inc., you are clearly leading the way to innovative non-drug therapies in #womenshealth?and leveraging #digitalhealth?to augment the experience for patients and providers. Cheers!
Cern Corporation has developed a microbicidal light device/treatment for BOTH yeast & bacterial vaginosis. The Cern Device...when drug based therapies are neither effective, appropriate, nor desired.
2 年Melanie Santos Grateful to have you as Cern's "partner" as we develop a new, treatment for mitigation of yeast and bacterial vaginosis...without drugs!
??? Host of MedTech's #1 Podcast | Helping Medtech Grow Sales Pipeline & Find Investors Using Social Media | Proud Husband & Father | Avid Reader | Jiu Jitsu @Carlson Gracie | Mentor | Coach
2 年Cern Corporation, Inc. great piece! Youre lucky to have a clinical leader like Melanie Santos helping to educate patients and pioneer a new way to understand/treat this.